Genomics

BEAST invests in Breakthrough Engineering, Applied Science and Technology startups across the UK and Continental Europe at the Seed stage. They focus on deep, frontier technologies with potential for health, climate, or societal impact, backing founders from inception and supporting growth.

Brightstone Venture Capital manages a $100 million venture fund focused on early-growth stage investments. They leverage the partners' deep operating experience and successful investment background, primarily investing in technology and life sciences sectors.

Civilization Ventures is a venture capital firm investing in scientific founders focused on cutting-edge innovations in health tech and biology. They support founders with a "mentor capital" approach, leveraging their vast network of experienced biopharma executives. Their investments span genomics, diagnostics, digital health, and synthetic biology.

Gigafund is a venture capital firm backing transformative entrepreneurs. They make long-term concentrated investments in founders capable of maximizing impact over decades, focusing on companies expected to be significant 20 years from now.

KdT Ventures is a venture capital firm specializing in early-stage frontier science investing. They focus on companies re-architecting the world at a molecular level, particularly in chemistry and biology. Their unique model allows for significant impact in the earliest stages of a venture.

ScaleX Ventures invests in exceptional founders from unexpected places, supporting their journey to global success. They provide resources and a platform to help founders overcome challenges and achieve significant growth. ScaleX partners with its portfolio companies, sharing in their success.